| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/01/2011 | US7897627 Heteroaryl derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897626 2-substituted thiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 03/01/2011 | US7897625 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 03/01/2011 | US7897624 Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors |
| 03/01/2011 | US7897623 ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors |
| 03/01/2011 | US7897622 Viral polymerase inhibitors |
| 03/01/2011 | US7897621 2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents |
| 03/01/2011 | US7897620 Methods of using anti-inflammatory compounds |
| 03/01/2011 | US7897619 Heterocyclic modulators of PKB |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897617 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/01/2011 | US7897616 Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases |
| 03/01/2011 | US7897615 Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors |
| 03/01/2011 | US7897614 Preventive agent/remedial agent for constipation predominant IBS |
| 03/01/2011 | US7897613 Crystalline polymorphs of clopidogrel |
| 03/01/2011 | US7897612 Substituted 1,8-naphthyridinecarboxamides for use as prolyl hydroxylase inhibitors |
| 03/01/2011 | US7897611 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
| 03/01/2011 | US7897610 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction |
| 03/01/2011 | US7897609 Aryl substituted imidazonaphthyridines |
| 03/01/2011 | US7897608 39-desmethoxy-39-methyl derivatives of rapamycin |
| 03/01/2011 | US7897607 Cyclic compounds |
| 03/01/2011 | US7897606 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands |
| 03/01/2011 | US7897605 Pyrimidine compounds |
| 03/01/2011 | US7897604 Inhibitors of polyisoprenylated methylated protein methyl esterase |
| 03/01/2011 | US7897603 Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 03/01/2011 | US7897602 Indolinone compounds as kinase inhibitors |
| 03/01/2011 | US7897601 Cannabinoid receptor modulators |
| 03/01/2011 | US7897600 Amino pyrazole compound |
| 03/01/2011 | US7897599 Cytokine inhibitors |
| 03/01/2011 | US7897598 Inhibiting transport of anandamide in an individual or animal comprising administering |
| 03/01/2011 | US7897597 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 03/01/2011 | US7897596 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina |
| 03/01/2011 | US7897595 Pyridoazepine derivatives |
| 03/01/2011 | US7897594 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 03/01/2011 | US7897593 HIV integrase inhibitors |
| 03/01/2011 | US7897592 HIV integrase inhibitors |
| 03/01/2011 | US7897590 Methods to mobilize progenitor/stem cells |
| 03/01/2011 | US7897589 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 03/01/2011 | US7897588 Agents and methods for enhancing bone formation |
| 03/01/2011 | US7897587 Topical dermatological formulations and use thereof |
| 03/01/2011 | US7897586 Veterinary medicine; aqueous solution containing cyclodextrins |
| 03/01/2011 | US7897584 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 03/01/2011 | US7897582 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein |
| 03/01/2011 | US7897580 β glycolipids as immuno-modulators |
| 03/01/2011 | US7897579 Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases |
| 03/01/2011 | US7897565 Compositions for HCV treatment |
| 03/01/2011 | US7897564 Flowable carrier matrix and methods for delivering to a patient |
| 03/01/2011 | US7897559 Acne; dermatitis |
| 03/01/2011 | US7897400 Non-invasive rapid diagnostic test for M. tuberculosis infection |
| 03/01/2011 | US7897397 Cell fusion promoter and utilization of the same |
| 03/01/2011 | US7897387 Fungal cell wall synthesis gene |
| 03/01/2011 | US7897326 Peroxisome-proliferator activated receptor-alpha agonists for organ preservation |
| 03/01/2011 | US7897182 Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
| 03/01/2011 | US7897181 Glass filters; anticancer agents |
| 03/01/2011 | US7897175 Cholesteryl ester transfer protein (CETP) such as torcetrapib; 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase); two drugs are separate from each other; improved chemical stability of the HMG-CoA reductase inhibitor |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | US7897172 Tablets exhibiting reduced drug release variability |
| 03/01/2011 | US7897169 Improved bioavailability; dairy products, sauces; antioxidant activity in ameliorative/preventive efficacy in hypercholesterolemia, hyperlipemia and atherosclerosis |
| 03/01/2011 | US7897166 Biodegradable ceramic fibres from silica sols |
| 03/01/2011 | US7897165 Covalent binding of a hydrogel to an extracellular matrix; primed extracellular matrix comprises tyrosyl radicals, polymerizable agent is an acrylate; tissue repair, delivery of drugs or cells |
| 03/01/2011 | US7897161 External medicine for treating dermatitis |
| 03/01/2011 | US7897160 Conjugated fatty acid based emulsion and methods for preparing and using same |
| 03/01/2011 | US7897156 Modified vaccinia virus ankara for the vaccination of neonates |
| 03/01/2011 | US7897152 Viral chemokine-antigen fusion proteins |
| 03/01/2011 | US7897144 Compositions containing legume products |
| 03/01/2011 | CA2677068A1 Nucleic acid compounds for inhibiting gene expression and uses thereof |
| 03/01/2011 | CA2626646C Carbazole derivatives as functional 5-ht6 ligands |
| 03/01/2011 | CA2602348C Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/01/2011 | CA2601999C Method for ameliorating pruritus |
| 03/01/2011 | CA2560689C Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes |
| 03/01/2011 | CA2542657C Muscarinic acetylcholine receptor antagonists |
| 03/01/2011 | CA2527088C Stabilized pharmaceutical product |
| 03/01/2011 | CA2512187C Use of derivatives of succinate esters for the treatment of dementia |
| 03/01/2011 | CA2511974C Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 03/01/2011 | CA2490878C Indole derivative and drug containing the same |
| 03/01/2011 | CA2468529C 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 03/01/2011 | CA2437240C Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 03/01/2011 | CA2423335C Spray drying process and compositions of fenofibrate |
| 03/01/2011 | CA2411660C Enzyme-cleavable prodrug compounds |
| 03/01/2011 | CA2396590C 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 03/01/2011 | CA2368618C Method of enhancing the efficacy of anti-tumor agents |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 02/28/2011 | CA2712848A1 A method of reducing cns and gastrointestinal side affects associated with long-term, dextromethorphan/low-dose quinidine combination therapy |
| 02/25/2011 | CA2676583A1 Substances for reducing occurrence of major cardiac events in humans |
| 02/24/2011 | WO2011022721A1 Inhibitors of botulinum neurotoxins |
| 02/24/2011 | WO2011022694A2 Furanopyrimidine cannabinoid compounds and related methods of use |
| 02/24/2011 | WO2011022692A2 Furanopyridine cannabinoid compounds and related methods of use |
| 02/24/2011 | WO2011022679A2 Benzofuran cannabinoid compounds and related methods of use |
| 02/24/2011 | WO2011022652A1 Topical gels |
| 02/24/2011 | WO2011022638A1 Trp inhibitors and uses thereof |
| 02/24/2011 | WO2011022633A2 Method of threating cancer |
| 02/24/2011 | WO2011022619A1 TREATING INFLAMMATORY DISEASES BY ADMINISTRATION OF REV-ERB α LIGANDS |
| 02/24/2011 | WO2011022606A2 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 02/24/2011 | WO2011022596A2 Preparation of bazedoxifene and its salts |
| 02/24/2011 | WO2011022548A2 Ketoreductase polypeptides for the preparation of phenylephrine |
| 02/24/2011 | WO2011022539A2 Methods for administration of colchicine with grapefruit juice |
| 02/24/2011 | WO2011022532A2 Methods for concomitant administration of colchicine and a second active agent |
| 02/24/2011 | WO2011022518A1 1,2,3,4-tetrahydroisoquinoline derivatives effective as antiglioma agents, methods of making, and their use |